InvestorsHub Logo

tredenwater2

07/24/23 12:08 AM

#424053 RE: Steady_T #424000

With all that going on I can see why Missling is being very careful. Anavex is already suspect because of its novel approach to CNS disease. Plenty of reasons not to give the critics any excuse to fault the findings.



Very logical thinking Steady but not that of a man out for a quick buck or by any other means one drawn any other way but to a traditional approach for getting an Alzheimer’s efficacious drug to market.

We have three types posting here these days two of which continue to thirst for money in the ways of the graveyards of BP. Some dinosaurs still refuse to die but make no mistake they are the wounded walking. Walking, clutching desperately to hope based on lies, greed, and fraud none of which is present in Anavex’s journey.

If we are going to avoid the same perilous journey they have succumbed to it will be by a novel unrecognizable, even totally obscure at times, approach that many might even confuse with failure. There is fear in the air, so thick it can be cut with a knife. Fear of separation with riches of this earth but what Anavex has to offer, when we make it to market, one can not put a price on. With our rigorous scientific trial methods embracing the why’s and how much or how little to whom and when, we continue to embarrass the present SOC if nothing else in our mere silence. Imo Dr. Missling is silently slicing them, killing them with a thousand cuts.

I say let them all price it now, daily, with their charts and (missed) timelines with vast fortunes from marginal efficacy. Let them feel they are in control if even only on the surface. Even if we dont soar to an unimaginable high in our MC, again, the real rewards may well be our own dignity we regain in our lives and in those of our loved ones.

Thanks again to those that are keeping it real in this period of company silence as we near this NDA period and thank you for not choosing to stoop or lose faith.

Cheers